• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶瘤病毒治疗与 IFN 的博弈。

The gamble between oncolytic virus therapy and IFN.

机构信息

College of Traditional Chinese medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Research Center for Infectious Diseases, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

出版信息

Front Immunol. 2022 Aug 25;13:971674. doi: 10.3389/fimmu.2022.971674. eCollection 2022.

DOI:10.3389/fimmu.2022.971674
PMID:36090998
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9453641/
Abstract

Various studies are being conducted on oncolytic virotherapy which one of the mechanisms is mediating interferon (IFN) production by it exerts antitumor effects. The antiviral effect of IFN itself has a negative impact on the inhibition of oncolytic virus or tumor eradication. Therefore, it is very critical to understand the mechanism of IFN regulation by oncolytic viruses, and to define its mechanism is of great significance for improving the antitumor effect of oncolytic viruses. This review focuses on the regulatory mechanisms of IFNs by various oncolytic viruses and their combination therapies. In addition, the exerting and the producing pathways of IFNs are briefly summarized, and some current issues are put forward.

摘要

目前正在进行多种溶瘤病毒治疗的研究,其中一种机制是通过介导干扰素(IFN)的产生来发挥抗肿瘤作用。IFN 本身的抗病毒作用对溶瘤病毒的抑制或肿瘤的清除有负面影响。因此,了解溶瘤病毒对 IFN 的调节机制非常关键,明确其机制对于提高溶瘤病毒的抗肿瘤效果具有重要意义。本综述重点介绍了各种溶瘤病毒及其联合治疗对 IFN 的调节机制。此外,还简要总结了 IFN 的作用和产生途径,并提出了一些当前存在的问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77e/9453641/b996f2fd4f05/fimmu-13-971674-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77e/9453641/80356787035b/fimmu-13-971674-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77e/9453641/c9e1b73a4440/fimmu-13-971674-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77e/9453641/b996f2fd4f05/fimmu-13-971674-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77e/9453641/80356787035b/fimmu-13-971674-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77e/9453641/c9e1b73a4440/fimmu-13-971674-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a77e/9453641/b996f2fd4f05/fimmu-13-971674-g003.jpg

相似文献

1
The gamble between oncolytic virus therapy and IFN.溶瘤病毒治疗与 IFN 的博弈。
Front Immunol. 2022 Aug 25;13:971674. doi: 10.3389/fimmu.2022.971674. eCollection 2022.
2
Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses.干扰素通路缺陷作为溶瘤病毒敏感性的潜在生物标志物。
Rev Med Virol. 2018 Nov;28(6):e2008. doi: 10.1002/rmv.2008. Epub 2018 Sep 13.
3
Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.β干扰素和α2a干扰素对头部和颈部癌细胞免受水疱性口炎病毒诱导的肿瘤溶解具有不同的保护作用。
J Virol. 2015 Aug;89(15):7944-54. doi: 10.1128/JVI.00757-15. Epub 2015 May 20.
4
Incorporation of the B18R gene of vaccinia virus into an oncolytic herpes simplex virus improves antitumor activity.将牛痘病毒的 B18R 基因掺入溶瘤单纯疱疹病毒可提高抗肿瘤活性。
Mol Ther. 2012 Oct;20(10):1871-81. doi: 10.1038/mt.2012.113. Epub 2012 Jun 12.
5
The pros and cons of interferons for oncolytic virotherapy.干扰素在溶瘤病毒治疗中的利弊。
Cytokine Growth Factor Rev. 2020 Dec;56:49-58. doi: 10.1016/j.cytogfr.2020.07.002. Epub 2020 Jul 3.
6
Interferon-Mediated Tumor Resistance to Oncolytic Virotherapy.干扰素介导的肿瘤对溶瘤病毒疗法的抗性。
J Cell Biochem. 2017 Aug;118(8):1994-1999. doi: 10.1002/jcb.25917. Epub 2017 Apr 25.
7
Oncolytic Sindbis virus targets tumors defective in the interferon response and induces significant bystander antitumor immunity in vivo.溶瘤性辛德比斯病毒靶向干扰素反应缺陷的肿瘤,并在体内诱导显著的旁观者抗肿瘤免疫。
Mol Ther. 2012 Feb;20(2):298-305. doi: 10.1038/mt.2011.245. Epub 2011 Nov 8.
8
Oncolytic Vaccinia Virus Expressing White-Spotted Charr Lectin Regulates Antiviral Response in Tumor Cells and Inhibits Tumor Growth In Vitro and In Vivo.表达白点鲑凝集素的溶瘤痘苗病毒调节肿瘤细胞中的抗病毒反应,并抑制体内外肿瘤生长。
Mar Drugs. 2021 May 21;19(6):292. doi: 10.3390/md19060292.
9
Updates to the antitumor mechanism of oncolytic virus.肿瘤溶瘤病毒抗肿瘤机制的研究进展。
Thorac Cancer. 2019 May;10(5):1031-1035. doi: 10.1111/1759-7714.13043. Epub 2019 Mar 22.
10
Oncolytic Virotherapy by HSV.单纯疱疹病毒溶瘤治疗。
Adv Exp Med Biol. 2018;1045:63-84. doi: 10.1007/978-981-10-7230-7_4.

引用本文的文献

1
The Generation of iPSCs Expressing Interferon-Beta Under Doxycycline-Inducible Control.在强力霉素诱导控制下表达β干扰素的诱导多能干细胞的产生。
Int J Mol Sci. 2025 Aug 28;26(17):8376. doi: 10.3390/ijms26178376.
2
Prefoldin complex promotes interferon-stimulated gene expression and is inhibited by rotavirus VP3.前折叠蛋白复合体促进干扰素刺激基因的表达,并受到轮状病毒VP3的抑制。
Nat Commun. 2025 Aug 29;16(1):8083. doi: 10.1038/s41467-025-63393-3.
3
A Type I IFN-Inducing Oncolytic Virus Improves NK Cell-Mediated Killing of Tumor Cells In Vitro Through Multiple Mechanisms.

本文引用的文献

1
Intravenous Oncolytic Vaccinia Virus Therapy Results in a Differential Immune Response between Cancer Patients.静脉内溶瘤痘苗病毒疗法导致癌症患者之间产生不同的免疫反应。
Cancers (Basel). 2022 Apr 27;14(9):2181. doi: 10.3390/cancers14092181.
2
IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity.IFNAR阻断与溶瘤性水疱性口炎病毒(VSV)协同作用,以防止病毒介导的PD-L1表达并促进抗肿瘤T细胞活性。
Mol Ther Oncolytics. 2022 Mar 16;25:16-30. doi: 10.1016/j.omto.2022.03.006. eCollection 2022 Jun 16.
3
Enhancement of CD70-specific CAR T treatment by IFN-γ released from oHSV-1-infected glioblastoma.
一种I型干扰素诱导溶瘤病毒通过多种机制增强自然杀伤细胞在体外对肿瘤细胞的杀伤作用。
Viruses. 2025 Jun 25;17(7):897. doi: 10.3390/v17070897.
4
Shaping viral immunotherapy towards cancer-targeted immunological cell death.将病毒免疫疗法导向癌症靶向性免疫细胞死亡。
Front Oncol. 2025 Jul 8;15:1540397. doi: 10.3389/fonc.2025.1540397. eCollection 2025.
5
Oncolytic virus therapy in hepatocellular carcinoma.肝细胞癌的溶瘤病毒疗法
Oncol Res. 2025 Jun 26;33(7):1593-1610. doi: 10.32604/or.2025.061857. eCollection 2025.
6
Measles Virus-Based Genetic Modifications: Progress in Hematological Malignancy Treatment.基于麻疹病毒的基因改造:血液系统恶性肿瘤治疗的进展
Onco Targets Ther. 2025 Apr 25;18:605-615. doi: 10.2147/OTT.S518407. eCollection 2025.
7
An oncolytic adenovirus targeting SLAMF7 demonstrates anti-myeloma efficacy.一种靶向信号淋巴细胞激活分子家族成员7(SLAMF7)的溶瘤腺病毒显示出抗骨髓瘤疗效。
Leukemia. 2025 Apr 17. doi: 10.1038/s41375-025-02617-3.
8
Oncolytic Viruses in Ovarian Cancer: Where Do We Stand? A Narrative Review.卵巢癌中的溶瘤病毒:我们目前的进展如何?一篇叙述性综述。
Pathogens. 2025 Feb 3;14(2):140. doi: 10.3390/pathogens14020140.
9
VAX014 Activates Tumor-Intrinsic STING and RIG-I to Promote the Development of Antitumor Immunity.VAX014激活肿瘤内在的STING和RIG-I以促进抗肿瘤免疫的发展。
Mol Cancer Ther. 2025 Apr 2;24(4):587-604. doi: 10.1158/1535-7163.MCT-24-0509.
10
Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis.溶瘤病毒治疗脑膜转移的挑战与策略。
J Transl Med. 2024 Nov 5;22(1):1000. doi: 10.1186/s12967-024-05794-4.
IFN-γ 从 oHSV-1 感染的脑胶质瘤中释放增强 CD70 特异性 CAR T 治疗。
Cancer Immunol Immunother. 2022 Oct;71(10):2433-2448. doi: 10.1007/s00262-022-03172-x. Epub 2022 Mar 6.
4
Oncolytic virus treatment differentially affects the CD56 and CD56 NK cell subsets in vivo and regulates a spectrum of human NK cell activity.溶瘤病毒治疗在体内对CD56及CD56 NK细胞亚群有不同影响,并调节一系列人类NK细胞活性。
Immunology. 2022 May;166(1):104-120. doi: 10.1111/imm.13453. Epub 2022 Mar 9.
5
Oncolytic Virotherapy: From Bench to Bedside.溶瘤病毒疗法:从实验台到临床应用
Front Cell Dev Biol. 2021 Nov 26;9:790150. doi: 10.3389/fcell.2021.790150. eCollection 2021.
6
NK cell tumor therapy modulated by UV-inactivated oncolytic herpes simplex virus type 2 and checkpoint inhibitors.由紫外线灭活的溶瘤单纯疱疹病毒 2 和检查点抑制剂调节的 NK 细胞肿瘤治疗。
Transl Res. 2022 Feb;240:64-86. doi: 10.1016/j.trsl.2021.10.006. Epub 2021 Oct 29.
7
Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colorectal cancer therapy.表达共刺激分子OX40L的溶瘤新城疫病毒作为免疫增强剂用于结直肠癌治疗
Gene Ther. 2023 Feb;30(1-2):64-74. doi: 10.1038/s41434-021-00256-8. Epub 2021 Oct 4.
8
Antitumor immunity enhancement through Newcastle viral oncolysate in mice model: A promising method to treat tumors.通过新城疫病毒溶瘤产物增强小鼠模型的抗肿瘤免疫力:一种有前景的肿瘤治疗方法。
Saudi J Biol Sci. 2021 Oct;28(10):5833-5840. doi: 10.1016/j.sjbs.2021.06.043. Epub 2021 Jun 18.
9
β-adrenergic receptor inhibition enhances oncolytic herpes virus propagation through STAT3 activation in gastric cancer.β-肾上腺素能受体抑制通过激活胃癌中的STAT3增强溶瘤性疱疹病毒的增殖。
Cell Biosci. 2021 Sep 20;11(1):174. doi: 10.1186/s13578-021-00687-1.
10
Induction of Robust Type I Interferon Levels by Oncolytic Reovirus Requires Both Viral Replication and Interferon-α/β Receptor Signaling.溶瘤呼肠孤病毒诱导产生强大的I型干扰素水平需要病毒复制和干扰素-α/β受体信号传导。
Hum Gene Ther. 2021 Oct;32(19-20):1171-1185. doi: 10.1089/hum.2021.140. Epub 2021 Sep 27.